Duplicate Subjects in Clinical Trials Proactively Detected and Prevented By Verified Clinical Trials

There are many obstacles to the success of a clinical trial and duplicate research subjects, or professional research subjects are unfortunately one of them. Duplicate subjects in clinical trials results in a myriad of poor outcomes. Ultimately duplicate research subjects can result in a clinical trial failing to meet its endpoints. And now with decentralized …

Read more

Duplicate Subjects In Clinical Trials and Decentralized Clinical Trials. Unique Issues With Professional Research Subjects

Interest in decentralized clinical trials has increased and has become quite popular. The adoption of these methods became acutely more appealing and necessary during the pandemic. Many research sites and clinical trial sponsors have adopted decentralized clinical trial methods. But decentralized clinical trials also come with unique challenges. To keep clinical trials safe, compliant, and effective, …

Read more

The Professional Research Subject Problem In Clinical Trials

Clinical research patients are compensated for their participation in clinical trials. In some therapeutic areas and types of clinical trials, the compensation for enrolling in one or more clinical trials or at multiple research sites is enough to influence patients to join more than one contemporaneously and expose themselves to multiple investigational products or multiple …

Read more

RESEARCH SITES AND SPONSORS COOPERATE TO PREVENT PROFESSIONAL RESEARCH SUBJECTS IN CNS CLINICAL TRIALS BY USING VERIFIED CLINICAL TRIALS

Duplicate subjects, or what is known as professional research subjects, exist in most clinical trials to varying degrees. CNS clinical trials are especially prone to duplicate subjects or over enrollment in clinical tials. The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications. Use of global …

Read more

Professional Research Subject Detection Now A Clinical Trial Essential

After more than a decade in the business of detecting “professional research subjects,” Verified Clinical Trials is a familiar name to stakeholders across the research enterprise—including the nefarious players who ride-share from city to city in search of unprotected sites where they can enroll in studies purely for the financial gain. It’s an underappreciated underground …

Read more

Screen Shot 2019 03 31 at 10.25.15 PM

Duplicate Or Professional Research Subjects Result In Failed Clinical Trials

Duplicate or professional research subjects can be the silent killer of your clinical trial. The issue exists in all phases of clinical trials research, across the globe and across most therapeutic areas. As the data grows, we realize how important it is to use the Verified Clinical Trials (VCT) research subject registry to prevent these …

Read more

Screen Shot 2019 07 26 at 9.37.51 AM

Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany

Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany. The meeting will include many of our current and future users of the VCT research subject database registry to prevent duplicate subjects in clinical trials and  as well as other protocol violations. The workshop …

Read more

Screen Shot 2018 06 27 at 11.15.03 PM

No Specific Characteristics Of A Duplicate Subject And A Research Subject Database Is Required

Without a “tool” such as the Verified Clinical Trials (VCT) global research subjects database registry, detecting duplicate subjects and protocol violations based upon prior study history or prior study drug (IP) exposure is impossible. VCT proactively detects these issues at the time of screening before costly screening procedures occur. The protections continue the entire duration …

Read more

Screen Shot 2019 04 30 at 4.03.56 PM

Verified Clinical Trials (VCT) will be exhibiting again at the EUFEMED meeting in France May 15-17. VCT is the global research subject database registry utilized by phase 1- phase 4 clinical trials across the globe. VCT prevents over enrollment or duplicate subjects as well as many other key protocol violations to promote safety and data …

Read more

Screen Shot 2018 03 27 at 8.51.00 PM

Duplicate Subjects In Clinical Trials Prevented By Verified Clinical Trials

Duplicate subjects in clinical trials has attracted the attention of many clinical trial managers and study leads.  To prevent duplicate subjects or professional research subjects, many sponsors have added the use of Verified Clinical Trials (VCT) as a mandatory step during the screening process.  VCT verifies a research subject’s study history at the time of …

Read more